XENE Xenon Pharmaceuticals Inc.
Healthcare$54.18+0.00%OpenMarket Cap: $4.28B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.54
P/S
0.00
EV/EBITDA
-9.37
DCF Value
$2.44
FCF Yield
-7.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-49.2%
ROA
-27.6%
ROIC
-30.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-112.3M | $-102.3M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-109.8M | $-105.3M | $— | — |
| FY null | $7.5M | 66.1% | $-373.1M | $-345.9M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-96.3M | $-90.9M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-94.2M | $-84.7M | $— | — |
| Q1 null | $7.5M | 100.0% | $-72.7M | $-65.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-77.5M | $-65.7M | $— | — |
| FY null | $0.00 | -Infinity% | $-279.3M | $-234.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-73.7M | $-62.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-69.1M | $-57.9M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-59.0M | $-47.9M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-53.7M | $-44.7M | $-0.64 | — |